Genesys Capital Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
6
- Investments
-
65
- Portfolio
-
11
- Exits
-
26
Genesys Capital General Information
Company Description
Founded in 2000, Genesys Capital is a venture capital firm based in Toronto, Canada. The firm seeks to invest in early-stage companies operating in the life sciences, biotechnology, pharmaceuticals, and medical technology sectors.
Business Details
Website
www.genesyscapital.comYear Founded
Investor Status
Trade Association
Primary Investor Type
Corporate Office
- 123 Front Street West
- Suite 1503, P.O. Box 34
- Toronto, Ontario M5J 2M2
- Canada
Genesys Capital Investments (65)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Feldan Therapeutics | 08-Aug-2024 | Later Stage VC | Biotechnology | Clinical Trials - Phase 1 | ||
| Afynia | 30-Jul-2024 | Diagnostic Equipment | Generating Revenue | |||
| Flosonics Medical | 14-Mar-2024 | Monitoring Equipment | Generating Revenue | |||
| CryoStasis | 27-Jul-2023 | Other Devices and Supplies | Startup | |||
| Veralox Therapeutics | 21-Jun-2023 | Drug Discovery | Generating Revenue | |||
| Inversago Pharma | 14-Oct-2022 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Giiant Pharma | 30-Jun-2021 | Drug Discovery | Pre-Clinical Trials | |||
| Veralox Therapeutics | 10-Jun-2021 | Drug Discovery | Generating Revenue | |||
| Flosonics Medical | 02-Feb-2021 | Later Stage VC | Monitoring Equipment | Generating Revenue | ||
| Inversago Pharma | 08-Sep-2020 | Later Stage VC | Drug Discovery | Clinical Trials - Phase 2 |
Genesys Capital Exits (26)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Inversago Pharma | 08-Sep-2023 | Merger/Acquisition | |
| Idbydna | 04-Jun-2022 | ||
| Profound Medical | 21-Jul-2020 | ||
| Fairhaven Pharmaceuticals | 16-Jul-2020 | ||
| Fusion Pharmaceuticals | 26-Jun-2020 | ||
| ImpoPharma | 25-Jul-2018 | ||
| Aptinyx | 21-Jun-2018 | ||
| Naurex | 28-Aug-2015 | ||
| Invitae | 12-Feb-2015 | IPO | |
| NeurAxon Pharma | 01-Jan-2015 | Merger/Acquisition |
Genesys Capital Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Genesys Capital Co-Investors (42)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Fonds de solidarite FTQ | 3 |
|
|
||
| Amgen Ventures |
|
|
|||
| Anges Québec |
|
|
|||
| CQDM |
|
|
|||
| GeneChem |
|
|
Genesys Capital FAQs
-
What is Genesys Capital?
Founded in 2000, Genesys Capital is a venture capital firm based in Toronto, Canada.
-
When was Genesys Capital founded?
Genesys Capital was founded in 2000.
-
Where is Genesys Capital headquartered?
Genesys Capital is headquartered in Toronto, Canada.
-
What is Genesys Capital's total asset value?
Genesys Capital has around in total assets under management.
-
How many investments has Genesys Capital made?
Genesys Capital has made 65 investments.
-
What has Genesys Capital invested in?
Genesys Capital has made numerous investments in companies like Feldan Therapeutics, Afynia, and Flosonics Medical within the Biotechnology, Diagnostic Equipment, and Monitoring Equipment industries.
-
What has Genesys Capital invested in recently?
Genesys Capital's latest investment was on 08-Aug-2024 in Feldan Therapeutics, a company within the Biotechnology industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
